help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 4, 2004
Molecular Endocrinology, doi:10.1210/me.2004-0308
A more recent version of this article appeared on March 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
19/3/588    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jamin, N.
Right arrow Articles by Lacapère, J.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jamin, N.
Right arrow Articles by Lacapère, J.-J.

Submitted on July 30, 2004
Accepted on October 27, 2004

Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor

Nadège Jamin*, Jean-Michel Neumann, Mariano A. Ostuni, Thi Kim Ngoc Vu, Zhi-Xing Yao, Samuel Murail, Jean-Claude Robert, Christoforos Giatzakis, Vassilios Papadopoulos, and Jean-Jacques Lacapère

CEA-Saclay, DBJC/SBFM and URA CNRS 2096, Bat 532 91191 Gif sur Yvette Cedex, France; Unité INSERM U410, Faculté de Médecine Xavier Bichat, 16 rue Henri Huchard, 75870 Paris Cedex 18, France; Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC 20057, USA

* To whom correspondence should be addressed. E-mail: jamin{at}dsvidf.cea.fr.

We previously defined a cholesterol recognition/interaction amino acid consensus sequence (CRAC: L/V-X (1-5)-Y-X (1-5)-R/K) in the carboxyl-terminus of the peripheral-type benzodiazepine receptor (PBR), a high affinity drug and cholesterol binding protein present in the outer mitochondrial membrane protein. This protein is involved in the regulation of cholesterol transport into the mitochondria, the rate-determining step in steroid biosynthesis. Reconstituted wild type recombinant PBR (recPBR) into proteoliposomes demonstrated high affinity PK 11195 and cholesterol binding. In the present work, we functionally and structurally characterized this CRAC motif using reconstituted recPBR and NMR. Deletion of the C-terminal domain of PBR and mutation of the highly conserved among all PBR amino acid sequences Y152 of the CRAC domain resulted in loss of the ability of mutant recPBR to bind cholesterol. NMR analysis of a PBR C-terminal peptide (144-169) containing the CRAC domain indicated a helical conformation for the L144-S159 fragment. As a result of the side-chain distribution, a groove that could fit a cholesterol molecule is delineated on one hand by Y152, T148 and L144, and on the other hand by Y153, M149 and A145. The aromatic rings of Y152 and Y153 assigned as essential residues for cholesterol binding constitute the gate of the groove. Furthermore, the side chain of R156 may cap the groove by interacting with the sterol hydroxyl group. These results provide structural and functional evidence supporting the finding that the CRAC domain in the cytosolic carboxyl-terminal domain of PBR might be responsible for the uptake and translocation of cholesterol into the mitochondria.


Key words: Peripheral-type benzodiazepine receptor • mitochondria • cholesterol recognition • mutations • NMR model • docking




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P.-Y. Wang, J. Weng, S. Lee, and R. G. W. Anderson
The N Terminus Controls Sterol Binding while the C Terminus Regulates the Scaffolding Function of OSBP
J. Biol. Chem., March 21, 2008; 283(12): 8034 - 8045.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. P. Palmer, R. Mahen, E. Schnell, M. B.A. Djamgoz, and E. Aydar
Sigma-1 Receptors Bind Cholesterol and Remodel Lipid Rafts in Breast Cancer Cell Lines
Cancer Res., December 1, 2007; 67(23): 11166 - 11175.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Bordet, B. Buisson, M. Michaud, C. Drouot, P. Galea, P. Delaage, N. P. Akentieva, A. S. Evers, D. F. Covey, M. A. Ostuni, et al.
Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 709 - 720.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. L. Miller
StAR Search--What We Know about How the Steroidogenic Acute Regulatory Protein Mediates Mitochondrial Cholesterol Import
Mol. Endocrinol., March 1, 2007; 21(3): 589 - 601.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Y. Baker, D. C. Yaworsky, and W. L. Miller
A pH-dependent Molten Globule Transition Is Required for Activity of the Steroidogenic Acute Regulatory Protein, StAR
J. Biol. Chem., December 16, 2005; 280(50): 41753 - 41760.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society